| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
insulin | 0.445 | 0.923 | 0.30 |
|
group | 0.700 | None | 0.963 | 0 | 0 | 1981 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.500 | None | 0.935 | 0 | 0 | 1999 | 2019 | ||||||||
|
ceruloplasmin | 0.466 | 0.846 | 4.2E-10 |
|
group | 0.460 | None | 1.000 | 0 | 0 | 1995 | 2017 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
group | 0.450 | None | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 | 0.626 | 0.500 | 0.80 |
|
group | 0.430 | strong | 1.000 | 0 | 0 | 2015 | 2017 | ||||||||
|
eukaryotic translation initiation factor 2 subunit gamma | 0.604 | 0.731 | 0.96 |
|
group | 0.410 | strong | 1.000 | 0 | 0 | 2002 | 2017 | ||||||||
|
ATP synthase F0 subunit 6 | 0.541 | 0.731 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2008 | 2008 | |||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
group | 0.380 | None | 1.000 | 0 | 0 | 2002 | 2018 | ||||||||
|
MAF bZIP transcription factor A | 0.751 | 0.269 | 3.4E-03 |
|
group | 0.320 | None | 1.000 | 0 | 0 | 2012 | 2013 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
group | 0.200 | None | 0.938 | 0 | 0 | 1991 | 2015 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
group | 0.200 | None | 0.810 | 0 | 0 | 2000 | 2019 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
group | 0.200 | None | 0.948 | 0 | 0 | 1992 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
group | 0.200 | None | 0.909 | 0 | 0 | 2006 | 2020 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
group | 0.200 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.200 | None | 0.971 | 0 | 0 | 1991 | 2019 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
group | 0.200 | None | 0.955 | 0 | 0 | 1994 | 2019 | ||||||||
|
paired box 4 | 0.644 | 0.423 | 4.2E-04 |
|
group | 0.200 | None | 1.000 | 0 | 0 | 1999 | 2018 | ||||||||
|
lamin A/C | 0.384 | 0.885 | 1.00 |
|
group | 0.200 | None | 0.727 | 0 | 0 | 2000 | 2015 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
group | 0.200 | None | 0.985 | 0 | 0 | 2003 | 2019 | ||||||||
|
pancreatic and duodenal homeobox 1 | 0.530 | 0.654 | 1.8E-02 |
|
group | 0.200 | None | 0.955 | 0 | 0 | 1998 | 2019 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
group | 0.200 | None | 0.965 | 0 | 0 | 1982 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.200 | None | 0.942 | 0 | 0 | 2001 | 2020 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
group | 0.200 | None | 1.000 | 0 | 0 | 2003 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.200 | None | 0.943 | 0 | 0 | 1986 | 2019 | ||||||||
|
frataxin | 0.510 | 0.654 | 0.34 |
|
group | 0.200 | None | 1.000 | 0 | 0 | 1988 | 2020 |